Streetbeat News

Stock Prices

XPRO

Expro Group has raised its FY2024 sales guidance from $1.60B-$1.70B to $1.70B-$1.75B, surpassing the $1.67B estimate. The company also refined its Adjusted EBITDA guidance to $350M-$375M. Third quarter revenue is expected to be $410M-$430M, with a sequential decrease but year-on-year growth of 14%.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:13 am

F

Ford shares are trading lower following a Q2 EPS miss.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:13 am

EW

Edwards Lifesciences shares are trading lower after the company reported worse-than-expected Q2 sales results and issued Q3 guidance below estimates. Additionally, the company acquired JenaValve and Endotronix.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:13 am

HON

Honeywell shares are trading lower after the company lowered its FY24 EPS guidance.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:12 am

FCFS

FirstCash Holdings (NASDAQ:FCFS) reported Q2 2024 adjusted EPS of $1.37, beating the estimate of $1.32. Sales were $831.012M, surpassing the $824.866M estimate. Both EPS and sales showed significant year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:11 am

WTW

Willis Towers Watson (NASDAQ:WTW) reported Q2 2024 adjusted EPS of $2.55, beating the estimate of $2.31, but sales of $2.265 billion missed the $2.273 billion estimate. EPS increased by 24.39% year-over-year, while sales grew by 4.91%.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:06 am

WST

West Pharmaceutical Services has revised its 2024 adjusted EPS guidance to $6.35-$6.65, down from the previous guidance of $7.63-$7.88 and below the consensus estimate of $7.74.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:05 am

LKQ

LKQ Corporation has lowered its FY24 adjusted EPS outlook from $3.90 - $4.20 to $3.50 - $3.70, compared to the $3.92 estimate.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:05 am

WST

West Pharmaceutical Services has updated its full-year 2024 net sales guidance to a range of $2.87 billion to $2.9 billion, down from the previous range of $3 billion to $3.025 billion. The company also adjusted its full-year 2024 adjusted-diluted EPS guidance to $6.35 to $6.65, down from the prior range of $7.63 to $7.88. Capital spending for the year is expected to increase to $375 million from the previous estimate of $350 million.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:05 am

LKQ

LKQ Corporation has revised its FY24 organic revenue growth outlook for Parts & Services from a range of 2.5% - 4.5% to a range of -1.25% to 0.25%.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:04 am